These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 661584)

  • 41. Suppression by autogenous complementary idiotypes: the priority of the first response.
    Rowley DA; Köhler H; Schreiber H; Kaye ST; Lorbach I
    J Exp Med; 1976 Oct; 144(4):946-59. PubMed ID: 62017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification of homogeneous murine immunoglobulins with anti-fructofuranan specificity.
    Vrana M; Tomasić J; Glaudemans CP
    J Immunol; 1976 Jun; 116(6):1662-3. PubMed ID: 1270808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific, immunologic regulation of differentiation of immunoglobulin expression in MOPC-315 cells during in vivo growth in diffusion chambers.
    Rohrer JW; Lynch RG
    J Immunol; 1977 Dec; 119(6):2045-53. PubMed ID: 72116
    [No Abstract]   [Full Text] [Related]  

  • 44. Suppression of myeloma growth in vitro by anti-idiotypic antibodies: inhibition of DNA synthesis and colony formation.
    Schreiber H; Leibson P
    J Natl Cancer Inst; 1978 Jan; 60(1):225-33. PubMed ID: 628019
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antigenic markers of variable region of mouse myeloma MOPC 21 light chain].
    Vengerova TI; Petrosian MN; Bogacheva GT; Rokhlin OV
    Mol Biol (Mosk); 1979; 13(6):1303-11. PubMed ID: 94936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contributions by ionic and steric features of ligands to their binding with phosphorylcholine-specific immunoglobulin IgA H-8 as determined by fluorescence spectroscopy.
    Bennett LG; Glaudemans CP
    Biochemistry; 1979 Jul; 18(15):3337-42. PubMed ID: 465473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The regulation of immunoglobulin synthesis and assembly.
    Baumal R; Coffino P; Bargellesi A; Buxbaum J; Laskov R; Scharff MD
    Ann N Y Acad Sci; 1971 Dec; 190():235-49. PubMed ID: 5290017
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasmacytomas of the NZB mouse.
    Morse HC; Riblet R; Asofsky R; Weigert M
    J Immunol; 1978 Nov; 121(5):1969-72. PubMed ID: 712074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combining sites of immunoglobulins that bind the 2,4-dinitrophenyl (DNP) group specifically.
    Haimovich J; Eisen HN; Givol D
    Ann N Y Acad Sci; 1971 Dec; 190():352-61. PubMed ID: 5290022
    [No Abstract]   [Full Text] [Related]  

  • 50. Expression and induction of MOPC-460 idiotopes in different strains of mice.
    Le Guern C; Ben Aïssa F; Juy D; Mariamé B; Buttin G; Cazenave PA
    Ann Immunol (Paris); 1979; 130(2):293-302. PubMed ID: 313747
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on J-chain biosynthesis in tumours producing immunoglobulins in NZB mice.
    Kaji H
    Biochem J; 1976 Jun; 156(3):681-4. PubMed ID: 821482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma cell tumour-formation and antigen-binding myeloma proteins in mice.
    Potter M
    Br Med J; 1971 May; 2(5757):320. PubMed ID: 4102509
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunoreactivity of solid phase hapten binding plasmacytoma protein (ABPC 24).
    Lehtonen OP
    Mol Immunol; 1981 Apr; 18(4):323-9. PubMed ID: 7300833
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular heterogeneity and fine specificity of BALB/c antibodies elicited by isologous myeloma protein.
    Odermatt BF; Perlmutter R; Lynch RG
    Eur J Immunol; 1978 Dec; 8(12):858-65. PubMed ID: 83235
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific isolation and characterization of antibody directed to binding site antigenic determinants.
    Claflin JL; Davie JM
    J Immunol; 1975 Jan; 114(1 Pt 1):70-5. PubMed ID: 46246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of tumor growth and antibody clone expression by antigen and anti-idiotype antibody ligands with specificity for receptor-binding sites.
    Bell C; Klein E
    Eur J Immunol; 1979 Oct; 9(10):762-8. PubMed ID: 520408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse.
    Lemke H; Hammerling GJ; Hohmann C; Rajewsky K
    Nature; 1978 Jan; 271(5642):249-51. PubMed ID: 74805
    [No Abstract]   [Full Text] [Related]  

  • 58. The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells.
    Segal DM; Titus JA
    J Immunol; 1978 Apr; 120(4):1395-403. PubMed ID: 641354
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumor immunity to murine plasma cell tumors. V. Demonstration of a unique tumor antigen that is not associated with the myeloma idiotype.
    MacKenzie MR; Burton RC; Warner NL
    Int J Cancer; 1978 Jun; 21(6):789-95. PubMed ID: 78916
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.